FCPM III Services’s Braveheart Bio BRVE Stock Holding History
Bought
Maintained
Sold
Other funds holding BRVE
FCPM III Services's BRVE Position: Q3 2026 in Review
FCPM III Services opened a new position in Braveheart Bio (BRVE) in Q3 2026: 21,826,024 shares worth $441M. The stake represents 41.57% of the portfolio and ranks #1 among its holdings.
64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.
- FCPM III Services held 21,826,024 shares of Braveheart Bio worth $441M as of Q3 2026.
- Braveheart Bio was a new FCPM III Services position in Q3 2026.
- Braveheart Bio made up 41.57% of FCPM III Services's portfolio in Q3 2026, its #1 holding.
- 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.
Based on FCPM III Services's 13F filing for Q3 2026, filed 16 Nov 2026.